Yahoo Web Search

Search results

1. • 

     Piper Sandler maintains OW on Teva Pharma shares after positive TEV-'749 survey By Investing.com

     Investing.com· 2 days ago

     On Thursday, Piper Sandler sustained its Overweight rating on shares of Teva Pharmaceutical...

2. • 

     Teva sues Corcept over mifepristone 'monopoly' for rare disorder

     Reuters via AOL· 2 days ago

     Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on...

3. • 

     There's Nothing Generic About Teva's Rally

     TheStreet.com· 2 days ago

     Now, let's let the charts determine our trading strategy from here. Shares of Teva Pharmaceutical Industries Ltd. (TEVA) made a base pattern on the...

4. • Public Employees Retirement Association of Colorado Grows Holdings in Teva Pharmaceutical Industries...

     ETF DAILY NEWS· 6 days ago

     Public Employees Retirement Association of Colorado increased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) ...

5. • Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know - Corcept Therapeutics...

     Benzinga· 19 hours ago

     Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceuticals Inc. (NYSE: TEVA) has sued the company, accusing it of a monopoly on Korlym.

6. • 

     Why Your Migraines Get Worse When It's Hot Outside

     SciTechDaily· 14 hours ago

     A recent study involving multiple research institutions found that increases in temperature significantly raise the likelihood of migraine attacks. The...

7. • Amneal, US FTC win order removing Teva inhaler patents from FDA list

     Reuters· 5 days ago

     Drugmaker Amneal Pharmaceuticals with the backing of the U.S. Federal Trade Commission convinced a New Jersey federal court on Monday to remove five Teva Pharmaceutical patents ...

8. • If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today - Teva Pharmaceutical...

     Benzinga· 3 days ago

     Teva Pharmaceutical Indus TEVA has outperformed the market over the past 5 years by 2.48% on an annualized basis producing an average annual return of 15.66% ...

9. • JD Supra: Federal Circuit Review

     JD Supra· 6 days ago

     In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No. 22-1258, the Federal Circuit held that district court erred by adding unclaimed limitations ...

10. • 

      AbbVie joins in latest gastrointestinal drug chase

      BioPharma Dive via Yahoo Finance· 1 day ago

      The Illinois-based drugmaker is following rivals like Merck, Roche, Teva and Sanofi, which have piled billions of dollars into acquisitions to gain...